The survey polled 1,004 U.S. adults.
Here are five survey findings:
1. A vast majority — 81 percent — are concerned about the implications of antibiotic resistance on infection treatment.
2. Seventy-three percent agree that the federal government should provide incentives to increase private sector investment in the development of new antibiotics, and 83 percent said pharmaceutical companies should develop more antibiotics.
3. Around 92 percent of adults polled said that physicians and other healthcare professionals should only prescribe antibiotics when needed.
4. Thirty-seven percent believe antibiotics are effective for treating viral infections, but they are not.
5. Additionally, 29 percent would be dissatisfied if their physician did not prescribe an antibiotic to treat their child’s viral infection.
More articles on healthcare quality:
Florida company aims to curb contamination by changing what sales reps wear in ORs
Drug-resistant infections linked to higher in-hospital mortality, study finds
Viewpoint: Nurses need to stop bullying EMS workers
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.